IASLC-LCRF Team Science Research Grant on Advancing Therapies Towards Curing Oncogenic-Driven Lung Cancers
This grant funds collaborative, interdisciplinary teams to develop innovative therapies for oncogene-driven lung cancers through integrated, multi-institutional research projects.
Funder: International Association for the Study of Lung Cancer
Due Dates (Anticipated): October 2026 (Letter of Intent) | January 2027 (Full application)
Funding Amounts: Up to $2.5 million total over four years for a multi-institutional team; one award anticipated.
Summary: Supports collaborative, interdisciplinary teams advancing therapies toward curing oncogene-driven lung cancers through integrated, innovative research projects.
Key Information: Large-scale, multi-year team science grant; teams must propose closely integrated projects with a unified goal.
Description
This opportunity is a major, multi-year team science grant designed to accelerate progress toward curing oncogene-driven lung cancers. The award supports a collaborative, interdisciplinary team of researchers working together on a tightly integrated program of projects. The objective is to advance therapeutic strategies for oncogenic-driven lung cancer, with a strong emphasis on synergy, innovation, and integration that cannot be achieved by individual efforts alone. Projects should be unified by a central goal and demonstrate a coordinated approach across team members and institutions.
